Advertisement

Topics

Common genetic fusion event could help identify patients with low-risk prostate cancer

00:30 EST 10 Nov 2017 | News-Medical.net

Establishing the way in which a genetic alteration called a TMPRSS2-ERG gene fusion forms in a prostate cancer, rather than the presence of the gene fusion itself, could help identify patients with prostate cancer with a low risk of spreading, which might determine the best course of treatment for the patient.

Original Article: Common genetic fusion event could help identify patients with low-risk prostate cancer

NEXT ARTICLE

More From BioPortfolio on "Common genetic fusion event could help identify patients with low-risk prostate cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...